1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
,
5 Global Platelet-rich Plasma Therapy (prp) Market, By Type
5.1 Introduction
5.2 Pure-Platelet-rich Plasma (P-PRP)
5.3 Leukocyte-rich Platelet-rich Plasma (L-PRP)
5.4 Pure-Platelet-rich Fibrin (P-PRF)
5.5 Leukocyte-rich Platelet-rich Fibrin (L-PRF)
5.6 Activated PRP
5.7 Autologous Conditioned Plasma (ACP)
5.8 Cellular PRP
5.9 Other Types
6 Global Platelet-rich Plasma Therapy (prp) Market, By Source
6.1 Introduction
6.2 Autologous
6.3 Allogenic
6.4 Other Sources
7 Global Platelet-rich Plasma Therapy (prp) Market, By Application
7.1 Introduction
7.2 Orthopedics
7.3 Dermatology
7.4 Dental
7.5 Sports Medicine
7.6 Chronic Wounds
7.7 Ophthalmology
7.8 Aesthetic Medicine
7.9 Cardiac Muscle Injury
7.10 Other Applications
8 Global Platelet-rich Plasma Therapy (prp) Market, By End User
8.1 Introduction
8.2 Hospitals
8.3 Clinics
8.4 Research and Academic Institutes
8.5 Other End Users
9 Global Platelet-rich Plasma Therapy (prp) Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Arthrex, Inc
11.2 Zimmer Biomet
11.3 EmCyte Corporation
11.4 Dr. PRP USA LLC
11.5 Juventix Regenerative Medical LLC
11.6 Johnson & Johnson Services, Inc.
11.7 Terumo Corporation
11.8 Stryker
11.9 Apex Biologix
11.10 Celling Biosciences, Inc
List of Tables
Table 1 Global Platelet-rich Plasma Therapy (prp) Market Outlook, By Region (2021-2030) ($MN)
Table 2 Global Platelet-rich Plasma Therapy (prp) Market Outlook, By Type (2021-2030) ($MN)
Table 3 Global Platelet-rich Plasma Therapy (prp) Market Outlook, By Pure-Platelet-rich Plasma (P-PRP) (2021-2030) ($MN)
Table 4 Global Platelet-rich Plasma Therapy (prp) Market Outlook, By Leukocyte-rich Platelet-rich Plasma (L-PRP) (2021-2030) ($MN)
Table 5 Global Platelet-rich Plasma Therapy (prp) Market Outlook, By Pure-Platelet-rich Fibrin (P-PRF) (2021-2030) ($MN)
Table 6 Global Platelet-rich Plasma Therapy (prp) Market Outlook, By Leukocyte-rich Platelet-rich Fibrin (L-PRF) (2021-2030) ($MN)
Table 7 Global Platelet-rich Plasma Therapy (prp) Market Outlook, By Activated PRP (2021-2030) ($MN)
Table 8 Global Platelet-rich Plasma Therapy (prp) Market Outlook, By Autologous Conditioned Plasma (ACP) (2021-2030) ($MN)
Table 9 Global Platelet-rich Plasma Therapy (prp) Market Outlook, By Cellular PRP (2021-2030) ($MN)
Table 10 Global Platelet-rich Plasma Therapy (prp) Market Outlook, By Other Types (2021-2030) ($MN)
Table 11 Global Platelet-rich Plasma Therapy (prp) Market Outlook, By Source (2021-2030) ($MN)
Table 12 Global Platelet-rich Plasma Therapy (prp) Market Outlook, By Autologous (2021-2030) ($MN)
Table 13 Global Platelet-rich Plasma Therapy (prp) Market Outlook, By Allogenic (2021-2030) ($MN)
Table 14 Global Platelet-rich Plasma Therapy (prp) Market Outlook, By Other Sources (2021-2030) ($MN)
Table 15 Global Platelet-rich Plasma Therapy (prp) Market Outlook, By Application (2021-2030) ($MN)
Table 16 Global Platelet-rich Plasma Therapy (prp) Market Outlook, By Orthopedics (2021-2030) ($MN)
Table 17 Global Platelet-rich Plasma Therapy (prp) Market Outlook, By Dermatology (2021-2030) ($MN)
Table 18 Global Platelet-rich Plasma Therapy (prp) Market Outlook, By Dental (2021-2030) ($MN)
Table 19 Global Platelet-rich Plasma Therapy (prp) Market Outlook, By Sports Medicine (2021-2030) ($MN)
Table 20 Global Platelet-rich Plasma Therapy (prp) Market Outlook, By Chronic Wounds (2021-2030) ($MN)
Table 21 Global Platelet-rich Plasma Therapy (prp) Market Outlook, By Ophthalmology (2021-2030) ($MN)
Table 22 Global Platelet-rich Plasma Therapy (prp) Market Outlook, By Aesthetic Medicine (2021-2030) ($MN)
Table 23 Global Platelet-rich Plasma Therapy (prp) Market Outlook, By Cardiac Muscle Injury (2021-2030) ($MN)
Table 24 Global Platelet-rich Plasma Therapy (prp) Market Outlook, By Other Applications (2021-2030) ($MN)
Table 25 Global Platelet-rich Plasma Therapy (prp) Market Outlook, By End User (2021-2030) ($MN)
Table 26 Global Platelet-rich Plasma Therapy (prp) Market Outlook, By Hospitals (2021-2030) ($MN)
Table 27 Global Platelet-rich Plasma Therapy (prp) Market Outlook, By Clinics (2021-2030) ($MN)
Table 28 Global Platelet-rich Plasma Therapy (prp) Market Outlook, By Research and Academic Institutes (2021-2030) ($MN)
Table 29 Global Platelet-rich Plasma Therapy (prp) Market Outlook, By Other End Users (2021-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
